In other words, almost all of the previous studies have focused on acquired resistance (which is caused by post-treatment changes such as alteration in drug targets and the activation of compensatory survival signaling pathways), while knowledge on intrinsic resistance (which includes the factors that exist before treatment such as the presence of cancer stem cells) is almost lacking in ALK+ cancers. The gene discussed is ALK; the disease is cancer.